Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease

Journal of Endocrinological Investigation

Volumn 22, Issue 1, 1999, Pages 23-28

  Arvat, E ^c   Ramunni, J ^c   Giordano, R ^c   Maccagno, B ^c   Broglio, F ^c   Benso, A ^c   Deghenghi, R ^a   Ghigo, E ^b  

^a Ardana   (France)

^b MOLINETTE HOSPITAL   (Italy)

^c NONE

Author keywords

ACTH; Cortisol; Cushing's disease; GH; hCRH; Hexarelin

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; HYDROCORTISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; CUSHING SYNDROME; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION;

EID: 0032969045     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345474     Document Type: Article

References (32)

1. Bowers C.Y., Veeraragavan K., Sethumadhavan K. Atypical growth hormone releasing peptides. In: Bercu B.B., Walker R.F. (Eds.), Growth hormone II, basic and clinical aspects. Springer-Verlag , New York, 1993, p. 203-222.
2. Ghigo E., Arvat E., Muccioli G., Camanni F. Growth hormone-releasing peptides. Eur. J. Endocrinol., 736: 445, 1997.
3. Smith R.G., Van der Ploeg L.X.T., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J., Fisher M.H., Nargund P.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev., 18: 621, 1997.
4. Deghenghi R., Boutignon F., Luoni M., Grilli R., Guidi M., Locatelli V. Small peptides as potent releasers of growth hormone. J. Red. Endocrinol. Metab., 8: 311, 1995.
5. Korbonits M., Grossman A.B. Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release. Trends Endocrinol. Metab., 6: 43, 1995.
6. Codd E.E., Shu A.Y.L, Walker R.F. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology, 28: 1139, 1989.
7. Pong S.S., Chaung L.Y.P., Dean D.C., Nargunt R.P., Patchett A.A., Smith R.G. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol., 10: 57, 1996.
8. 125I] p-benzoyl-phenylalanine Hexarelin derivative. Endocrinology, 739: 432, 1998.
9. Muccioli G, Ghè C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F., Nilsson M.H.L., Deghenghi R., Ong H., Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol., 157: 99, 1998.
10. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Uamelin M., Ureniuk D.I., Palyhe O.C., Anderson J., Paress P.S., Diaz C., Chou N., Liu K.K., McKee K.K., Pong S.S., Cheung L.Y., Elbrecth A., Dashkeviez M., Keavehs R., Rishy M., Siringjhsinghji D.J.S., Dean D.C., Melillo D.G., Patchett A.A., Nergund R., Srillin P.R. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974, 1996.
11. Goth M.I., Lyons C.E., Canny B.Y., Thorner M.O. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 130: 939, 1992.
12. Fairhall K.M., Mynett A., Robinson I.C.A.F. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J. Endocrinol. 144: 555, 1995.
13. Dickson S.L., Luckman S.M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 138: 771, 1997.
14. Popovic V., Damjanovic S., Micic D., Djurovic M., Dieguez C., Casanueva F.F. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J. Clin. Endocrinol. Metab. 80: 942, 1995.
15. Pombo M., Barreiro J., Penalva A., Peino R., Dieguez C., Casanueva F.F. Absence of growth hormone (GH) secretion after the administration of either GH releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J. Clin. Endocrinol. Metab. 80: 3180, 1995.
16. Loche S., Cambiaso P., Merola B., Colao A., Feadda A., Imbimbo B.P., Deghenghi R., Lombardi G., Cappa M. The effect of Hexarelin on growth hormone (GH) secretion in patients with GH deficiency. J. Clin. Endocrinol. Metab. 80: 2692, 1995.
17. Hickey G.J., Drisko J., Faidley T., Chang C., Anderson L., Nicolich S., McGuire L., Riches E., Kripe D., Feeney W., Friscino R., Cunnighan P., Frazier E., Chen H., Leroque P., Smith R.G. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J. Endocrinol. 148: 371, 1996.
18. De Keyzer Y., Lenne F., Bertagna X. Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors. Eur. J. Endocrinol. 737: 715, 1997.
19. Jansson J.O., Svensson J., Bengtsson B.A., Frohman L.A., Ahlmant H., Wangberg B., Nilsson O., Nilsson M. Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6. Clin. Endocrinol. (Oxf.) 48: 243, 1998.
20. Thomas G.B., Fairhall K.M., Robinson I.C.A.F. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138: 1585, 1997.
21. Korbonits M., Trainer P.J., Besser G.M. The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin. Endocrinol. (Oxf.) 43: 365, 1995.
22. Arvat E., Maccagno B., Ramunni J., Di Vito L., Broglio F., Deghenghi R., Camanni F., Ghigo E. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-reieasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Neuroendocrinology 66: 432, 1997.
23. Ghigo E., Arvat E., Ramunni J., Colao A., Gianotti L., Deghenghi R., Lombardi G., Camanni F. Adrenocorticotropin-and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 82: 2439, 1997.
24. Orth D.N. Corticotropin-releasing hormone in humans. Endocr. Rev. 73: 164, 1992.
25. Copinschi G., van Onderbergen A., L'hermite-Baleriaux M., Mendel C.M., Caufriez A., Leproult R., Bolognese J.A., De Smet M., Thorner M.O., Van Cauter E. Effects of 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, Insulin-like growth factor I, and adrenocortical function in normal young men. J. Clin. Endocrinol. Metab. 81: 2776, 1996.
26. Jacks T., Hickey G., Judith F., Taylor J., Chen H., Krupa D., Feeney W., Schoen W., Fisher M., Wyratt M., Smith R. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. J. Endocrinol. 143: 399, 1994.
27. Arvat E., Maccagno B., Ramunni J., Di Vito L., Gianotti L., Broglio F., Benso A., Deghenghi R., Camanni F., Ghigo E. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of Hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans. Neuroendocrinology, 67: 310, 1998.
28. th European Congress on obesity Dublin, 1997. Int. J. Obes., 21: 181 (Abstract) S61, 1997.
29. th Ann. Meet. Endocr. Soc., Minneapolis, 1997, p. 153.
30. Arvat E., Maccagno B., Ramunni J., Gianotti L., Di Vito L., Deghenghi R., Camanni F., Ghigo E. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man. J. Endocrinol. Invest. 20: 122, 1997.
31. Di Vito L., Arvat E., Gianotti L., Broglio F., Sortino G., Lanfranco F., Deghenghi R., Ghigo E. Influence of galanin and serotonin on the GH, PRL, ACTH and cortisol response to Hexarelin, a synthetic GHRP, in humans. Ann. Endocr, 58: 86 (Abstract) P1-6, 1997.
32. th international Pituitary Congress, 1998. Abstract book p. 60.